|
| |
TachycardiaTachycardia is a form of cardiac arrhythmia which refers to a rapid beating of the heart. By convention the term refers to heart rates greater than 100 beats per minute in the adult patient. Tachycardia may be a perfectly normal physiological response to stress. However, depending on the mechanism of the tachycardia and the health status of the patient, tachycardia may be harmful, and require medical treatment. In extreme cases, tachycardia can be life threatening.Tachycardia can be harmful in three ways. Firstly, if the heart is pumping too fast for an extended period of time it will change the balance of oxygen and carbon dioxide in the hemoglobin in the blood; this is normal during exercise but when resting this is quite dangerous. Second, when the heart beats too rapidly, it may pump blood less efficiently. Thirdly, the faster the heart beats, the more oxygen and nutrients the heart requires. This may leave patients feeling out of breath or cause angina. This can be especially problematic for patients suffering from ischemic heart disease. (From the Wikpedia article Tachycardia.) Download PDF containing detailed information.
Recent Publications on Tachycardia: |  |
Diastolic Intracellular Calcium-Membrane Voltage Coupling Gain and Postshock Arrhythmias. Role of Purkinje Fibers and Triggered Activity.
Rationale: Recurrent ventricular arrhythmias after initial successful... | 21st November, 2009
| Krannert Institute of Cardiology and the Division of Cardiology,
| Circ Res. 2009 Nov 19.
DOI Direct Link |
Octopus Papillary Muscle Associated with a Left Lateral Accessory Pathway.
Left ventricular papillary muscle abnormalities are rare malformations.... | 21st November, 2009
| Adult Congenital Heart Disease Center, Emory University, Atlanta, Ga, USA;
| Congenit Heart Dis. 2009 Nov;4(6):481-484.
DOI Direct Link |
Is the Mechanism of Supraventricular Tachycardia in Pediatrics Influenced by Age, Gender or Ethnicity?
Background. The mechanism of supraventricular tachycardia (SVT) in adults... | 21st November, 2009
| Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA, USA.
| Congenit Heart Dis. 2009 Nov;4(6):464-468.
DOI Direct Link |
Bradypedia: Is Gait Speed Ready for Cinical Use?
Mobility, or locomotion, could be considered a distinguishing feature of... | 20th November, 2009
| S. Studenski, University of Pittsburgh, Staff Physician, Pittsburgh
| J Nutr Health Aging. 2009;13(10):878-880.
|
Anesthetic management of a patient with hyperthyroidism due to hydatidiform mole.
Secondary hyperthyroidism can often complicate gestational trophoblastic... | 19th November, 2009
| Department of Anesthesiology and Intensive Care Medicine, 1-1
| J Anesth. 2009 Nov;23(4):594-596. Epub 2009 Nov 18.
DOI Direct Link |
→View more research publications. |
Press Releases About Tachycardia:
|
 |
| Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2009 |
11th May, 2009 |
Stereotaxis, Inc. |
Remote Magnetic Navigation prominently featured on the HRS 2009 program
ST. LOUIS, May 11 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) said today that the Heart Rhythm 2009 formal
|
| Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent |
27th February, 2009 |
Novalar |
CHICAGO, Feb. 27 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company today announced the launch of OraVerse(TM), the company's premier dental pharmaceutical
|
| Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia |
5th January, 2009 |
Prism Pharmaceuticals |
KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals
announced today that the U.S. Food & Drug Administration (FDA) has approved
the new drug application (NDA) for NEXTERONE(R)
|
| Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent |
12th August, 2008 |
Novalar Pharmaceuticals, Inc. |
SAN DIEGO, Aug. 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental
specialty pharmaceutical company, announced the publication of three clinical
trials on the use of OraVerse (phentolamine
|
Companies working in the area of Tachycardia from Bioportfolio's Biocorporate database : | |
| Company Name | |
Cardima®, Inc. is developing minimally invasive, single-use, microcatheter-based systems for the mapping and ablation of the two most common forms of cardiac arrhythmias: atrial fibrillation ("AF")...
www.Cardima.com/ View full profile
| |
Arrhythmia Research Technology, Inc. (ART) was founded in 1981 specifically to capitalize on the marketing of certain patents or licenses concerning the application of signal-averaged...
www.arthrt.com/ View full profile
| |
BioPortfolio Ltd. offers e-mail and postal lists for Tachycardia scientists - we have details of around 4838 individuals working on Tachycardia .
This page has been viewed 475 times
Recent Search Terms used to find this page: extreme tachycardia during exercise | extreme tachycardia | extreme tachycardia | extreme tachycardia | carbon dioxide a cure for arrhythmia | extreme tachycardia | extreme cases of tachycardia | extreme tachycardia | extreme tachycardia | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Tachycardia across BioPortfolio, or for Tachycardia Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
